Related Experiment Videos
Compliance with medication regimens for mental and physical disorders
1Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Psychiatric Services (Washington, D.C.)
|May 9, 1998
Summary
Medication compliance in psychiatric treatment appears lower than for physical disorders, but this may be due to varied assessment methods. Improved monitoring and adherence strategies are needed for psychiatric pharmacotherapy.
Area of Science:
- Psychiatry
- Pharmacology
- Health Services Research
Background:
- Medication compliance is crucial for effective psychiatric treatment.
- Understanding compliance rates in psychiatric versus physical disorders is essential for optimizing patient outcomes.
- Existing research presents varied compliance rates, necessitating a comparative analysis.
Purpose of the Study:
- To review and compare medication compliance rates in psychiatric disorders with those in physical disorders.
- To evaluate the methods used for assessing medication compliance in psychiatric populations.
- To identify potential discrepancies in compliance rates attributable to assessment methodologies.
Main Methods:
- A literature search of MEDLINE (1975-1996) was conducted for studies on medication compliance in psychiatric treatment.
- Reports on antidepressant and antipsychotic medication compliance were selected, alongside studies using microelectronic monitoring for non-psychiatric disorders.
- Methods for compliance assessment and reported rates were critically reviewed and compared.
Main Results:
- Psychiatric patients exhibited lower average compliance rates: 58% for antipsychotics and 65% for antidepressants.
- Compliance rates for physical disorders, assessed via microelectronic monitoring, averaged 76%.
- Varied assessment methods (interviews, clinician judgment, pill counts) in psychiatric studies may inflate perceived non-compliance.
Conclusions:
- Medication adherence may indeed be lower in psychiatric disorders compared to physical ailments.
- The disparity in compliance rates could be significantly influenced by the chosen methods of assessment.
- Development of novel and enhanced compliance monitoring tools and adherence interventions is warranted for psychiatric pharmacotherapy.